Previously, a nationwide shortage in GLP-1 medications made it possible to access compounded versions of the drugs, but the FDA has officially announced the end of that shortage and said it will take decisive steps to restrict companies making compounded GLP-1s from accessing those ingredients
These often occur within a week of starting semaglutide, though noticeable changes in weight or blood sugar take longer
FDA proposes broad approach for conducting safety trials for type 2 diabetes medications (2020)
This allows patients and healthcare providers to weigh the benefits against potential risks and choose the most appropriate course of action
Because of this, healthcare professionals recommend that people trying to conceive should stop taking these medications a few months before trying to become pregnant
Ongoing research and clinical trials continue to uncover the full potential of semaglutide, solidifying its status as a treatment option for improving overall health and well-being through weight loss